Nutriearth opens first European plant in France
From left to right: Jérémy Defrize, Co-founder of Nutriearth; Philippe Beauchamps, Vice-President of the Hauts-de-France Region in charge of business relations, employment and training; Frédéric Motte, Regional Councillor Delegate for Regional Economic Transformation and President of the Rev3 mission; and Jeremy Burks, CEO of Nutriearth.
Nutriearth, a leader in natural and sustainable vitamin D3 production from edible insects, has officially launched its first commercial manufacturing facility in Carvin, France.
This cutting-edge site, backed by major investors and regional partners, marks the company’s leap to industrial scale, ready to supply the global markets for human nutrition and health, as well as pet food, animal feed, functional foods, and nutraceuticals.
The new facility, developed after a €7.45 million fundraising round, brings together Nutriearth’s R&D, quality control, and production under pharmaceutical-grade principles.
The site adheres to strict cleanroom standards with separate production lines for its two vitamin D3 formats: oil and powder. All ingredients are manufactured entirely on-site, providing a local, traceable, and sustainable supply of vitamin D3 for European and international customers.
This local production aims to significantly reduce Europe’s dependence on imports from China and India, which currently dominate 99.9% of the global vitamin D3 market.
Nutriearth’s Nutra-oil is already approved for supplements and functional foods in North America. Its functional flour, N-utra, received European Commission approval in February 2025, opening up major new opportunities across Europe.
CEO Jeremy Burks noted that the Carvin site has the capacity to cover the vitamin D3 needs of over 50 million people, supporting healthier lives globally with a nature-based solution.
Nutriearth is tackling the global vitamin D deficiency crisis (which affects nearly half the world’s population) with a revolutionary, patented process that utilises the mealworm (Tenebrio molitor).
The innovation involves exposing mealworm flour, which is naturally rich in a vitamin D3 precursor, to a specific type of light. This mimics the body’s natural synthesis to convert the precursor into bioactive, highly absorbable vitamin D3, all without chemical extraction, solvents, or additives.
Scientific studies show Nutriearth’s vitamin D3 is absorbed up to three times better than vitamin D3 derived from lanolin and twice as well as that from lichen—both of which rely on multi-step chemical processes.
An independent life cycle assessment found the process results in 76.8% lower greenhouse gas emissions and an eightfold lower total environmental impact compared to lanolin-derived vitamin D3.
Regional vice-president Philippe Beauchamps praised Nutriearth as a “perfect example” of the industrial projects the Hauts-de-France Region seeks to promote. “By supporting Nutriearth…the Region is reaffirming its commitment to backing forward-looking industrial projects that create jobs while also providing tangible solutions to public health and ecological transition challenges,” Beauchamps stated.
CEO Jeremy Burks thanked the strong network of investors and partners, including Demeter Investment Managers, Captech Santé, and BPI France, for bringing the long-term vision to life and accelerating the company’s growth into a major global vitamin D3 player.
